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1 Introduction
Alterations in the complex immunoregulatory
mechanisms during pregnancy must exist to
explain survival to term of the histoincompati-
ble embryo and fetus. Both the recognitive and
the effector immune capabilities of the pregnant
female have been examined in a number of
studies and, although the results are conflicting,
some evidence appears to support a suppression
of these capabilities. In fact, reduction of ma-
ternal immunological responsiveness is sug-
gested by prolonged periods of survival of skin
allografts [3], by an augmented susceptibility of
viral infections during pregnancy [13], by lack
of cytotoxic effector cells directed specifically
against paternal target cells [27], and by specific
hyporesponsiveness to paternal alloantigens at
the humoral level [12]. The intrinsic inhibition
of maternal lymphocyte reactivity initially pro-
posed [24] seems, on the other hand, to be
giving place to the presence of inhibitory factors
of lymphocyte transformation in serum of gra-
vidas [11,23]. Blocking antibodies [25], suppres-
sor cells [28], and lack of antigen presentation
on trophoblasts [31] appear to critically contrib-
ute to fetal non-rejection.
Among the suppressor factors present in preg-
nancy serum, α-fetoprotein (AFP) is one of the
most investigated. Although high levels of AFP
during pregnancy indicate an essential role,
nothing conclusive is known about its function.
According to some investigators, AFP is immu-
nosuppressive [14, 17, 18], but others have not
found any suppression in in vitro systems and
have even noted a stimulatory action for AFP
[8, 15].
We have already demonstrated that PHA lym-
phocyte proliferation, the simplest and most
reproductible in vitro correlate of cell-mediated
immunity [21], is not influenced by the levels
of AFP encountered in pregnancy serum [23],
in cord serum [32] and also in amniotic fluid
[33]. Altered concentrations of immunoglobu-
lins during pregnancy have been described and
the findings of some investigators suggest that
AFP may act on humoral immunity [4, 5, 17,
20, 29, 30]. The present study was designed to
firstly compare the levels of the immunoglobu-
lins G, M and A in sera of women at various
stages of gestation and in sera of age matched
non-pregnant females. Secondly, the levels of
the immunoglobulins were correlated with the
levels of AFP in gravidas' sera as an attempt to
examine a possible action of AFP on humoral
immunity.
2 Material and methods
2.1 Serum
Peripheral blood samples were obtained from
randomly selected pregnant volunteers at va-
rious stages of gestation (11 — 14 weeks, 32 — 34
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weeks and 38—40 weeks), attending the Ante-
natal Clinic of Newcastle General Hospital, and
from non-pregnant healthy female volunteers
among the nursing staff of the same hospital
during 12 weeks in 1982. Control subjects (non-
pregnant women) were matched for age. Gesta-
tional age was calculated from the date of last
menstrual period and confirmed by clinical
examination. Patients were excluded from the
Study for the following reasons: uncertain ges-
tation age, manifested infection, history of al-
lergy, diabetes, hypertension or other medical
problems, symptoms or signs of threatened
abortion, fetal death, suspected twins and pre-
vious birth of a child with neural tube defect.
The serum was separated from the cells by
centrifugation and kept frozen at —20 °C until
tested.
2.2 α-fetoprotein assay
Estimation of AFP was performed using the
radioimmunoassay (RIA, Gnost Kit of Hoechst
Behringwerke). Duplicate estimations were
made for each specimen. Within duplicates, the
mean coefficient of variation was 4.21%. If
within duplicates this coefficient was higher
than 10% for a given sample, the estimation
was repeated. Results are expressed as nano-
grams per milliliter.
2.3 Immunoglobulins assay
Immunoglobulin G (IgG), immunoglobulin M
(IgM) and immunoglobulin A (IgA) were deter-
mined by single radial immunodiffusion using
Tri-Partigen plates of Hoechst Behringwerke.
The mean coefficient of variation within dupli-
cates for IgG, IgM and IgA were respectively
3.54%, 2.63% and 2.86%. Results are ex-
pressed as milligrams per cent.
2.4 Statistics
The statistical comparisons utilized were analy-
sis of variance (F, Duncan New Multiple Range
Test), Pearson linear and partial correlations.
The raw data were applied wherever possible.
In some cases a logarithmic transformation was
necessary. Values of P < 0.05 were considered
significant.
3 Results
3.1 Serum immunoglobulins and AFP levels
during normal pregnancy
The mean concentrations of serum immuno-
globulins G, M and A at 11-14, 32-34 and
38 — 40 weeks of gestation and those of non-
pregnant controls, as well as AFP mean levels
in pregnancy serum, are given in table I. The
standard deviation and number of samples in
each group are also given. Mean serum AFP
levels are not presented in controls, since they
were below the sensitivity of the RIA Kit em-
ployed in this study. All values were less than
10ng/ml. The concentrations of IgG are de-
creased throughout gestation; whereas, IgM
levels are diminished at around the beginning
of the third trimester. A gradual increase in
AFP concentrations as pregnancy advances was
also found.
3.2 Relationship between AFP and immuno-
globulins levels in pregnancy serum
Table II demonstrates the zero-order Pearson
linear coefficients of correlation calculated be-
tween AFP and IgG, IgM and IgA levels in
pregnancy serum, as well as the number of
variable pairs and probabilities. The table fur-
ther presents the partial correlation coefficiency
values, keeping gestational age constant. It can
be seen from the coefficiency values that AFP
correlates negatively with all immunoglobulins,
but significance was demonstrated only with
IgG. When gestational age was fixed, the corre-
lation (partial coefficients) remained significant
for IgG.
Correlation between AFP and IgG levels within
each gestational age was then determined to
establish whether there is a certain period in
which the association is stronger. In this case,
a logarithmic transformation was necessary for
AFP values, since they were somewhat skewed
to the right. These coefficients at 11 — 14,
32 — 34 and 30—40 weeks of gestation appear
in table III together with the number of variable
pairs and probabilities. All coefficients were
significant and no relevant difference between
probabilities was observed.
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Table I. Serum immunoglobulins and α-fetoprotein levels (mean + S. D.) in pregnancy.
Controls
Gestation
11-14 wks
32-34wks
30-40 wks
FProb
IgA
(mg%)
180 + 69
(n = 57)
170 + 52
(n = 26)
179 + 73
(n = 37)
181 + 58
(n = 38)
>0.05
IgM
(mg%)
172 + 67
(n = 57)
167 + 68
(n = 26)
147 + 58
(n = 37)
179 + 70
(n = 38)
>0.05
IgG ProbA
(mg%)
1430 + 313
(n = 57)
1158 + 275 *
(n = 26)
1020 + 279 *
(n = 37)
967 + 218 *
(n = 38)
<0.05
AFP
(ng/ml)
32
(n =
220
(n =
228
(n =
+ 22
= 26)
+ 110
= 37)
±81
= 38)
A
 Probabilities of the mean immunoglobulin differences between controls and samples from pregnant females at
the various gestational ages taken separately calculated by the Duncan multiple range test.
* Significant
Table Π. Relationship between α-fetoprotein and immunoglobulin G, M and A levels in pregnancy sera.
AFP-IgG
AFP-IgM
AFP-IgA
Pearson
coefficient
r
-0.261
-0.156
-0.037
No. of
samples
101
101
101
F
Probability
0.004
0.058
0.354
Partial coefficient
with gestation
age fixed
-0.181
-0.114
-0.052
No. of
samples
100
100
100
F
Probability
0.035
0.127
0.300
Regression analyses were performed on individual paired samples.
Table ΙΠ. Relationship between α-fetoprotein and immunoglobulin G serum levels at three different stages of
pregnancy.
Weeks of
gestation
11-14
32-34
38-40
Pearson
coefficient
r
-0.435
-0.335
-0.366
No. of
samples
26
37
38
F
Probability
0.019
0.018
0.010
Partial coefficient
with gestation
age fixed
-0.485
-0.338
-0.352
No. of
samples
25
36
37
F
Probability
0.011
0.019
0.014
iscussion associated α-2-globulin [10],
Several substances encountered in high concen- pregnancy specific -1-glycoprotein [η and α-
tration in pregnancy sera have been shown to fetoprotein [14, 17, 18] are among them. Specifi-
possess immunosuppressive properties. Hor- cally regarding AFP, the results are contradic-
mones such as human chorionic gonadotrophin tory [8, 15]. Our previous studies strongly sug-
[1], human chorionic somatomammotrophin gest that AFP is not principally involved with
[9], progesterone [16] and human placental lac- the in vitro depression of cell mediated immun-
togen [7] and proteins raised during pregnancy ity caused by sera of gravidas and newborns
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respectively [23, 32] nor by human amniotic
fluid [33]. This study firstly approached humo-
ral immunity of gravidas by studying the levels
of immunoglobulins in pregnancy sera. We
found consistently diminished IgG serum levels
throughout gestation. Data published in the
literature differ regarding the levels of the va-
rious immunoglobulins during pregnancy, but
it has been generally found that IgG concentra-
tions are diminished during gestation in accord-
ance with our results [4, 22, 29, 30]. The present
investigation also demonstrated a significant
negative correlation between AFP and IgG
levels. To our knowledge nothing has been so
far published on this matter nevertheless, some
investigators tried to correlate immunoglobu-
lins with AFP levels in cord serum [6, 26].
CEDERQVIST et al. [6] found no association,
whereas SCHUURMAN et al. [26] encountered a
relationship between low cord IgA concentra-
tions and high AFP levels at term. The relation-
ship encountered in the present work is difficult
to interpret since it may represent a false associ-
ation. In view of various studies indicating that
AFP acts at the level of the cellular interactions
which lead to IgG production [2, 17, 19, 20], it
is tempting to speculate that AFP may be in-
volved in the determination of the final concen-
trations of IgG in maternal circulation. OGRA
et al. (1974) reported that amniotic fluid AFP
suppresses antibody synthesis when adminis-
tered in vivo [20]. MURGITA and TOMASI demon-
strated that pure AFP inhibits the in vitro pri-
mary IgM and secondary IgA and IgG anti-
body response in mice [17]. MURGITA et al. [19]
in turn proved that murine AFP induces the
formation of a suppressor T cell population,
and this was also demonstrated in humans by
ALPERT'S investigations [2]. Since it is estab-
lished that these suppressor cells are able to
inhibit helper T cells ultimately linked to anti-
body production after proper stimulation of B
cells, an immunosuppressive effect of a-feto-
protein during pregnancy limited to a certain
population of lymphocytes responsible for a
monoclonal suppression of cells involved in
IgG synthesis is possible. If this is correct, the
presently accepted lack of influence of AFP on
cellular immunity may be due to the fact that
this subpopulation of cells is too small to be
detected in the cellular growth response experi-
ments which were used as a screen to identify
alterations of cell mediated immunity.
Summary
The immunoregulatory processes operating during preg-
nancy that allow the survival of the semiallogeneic con-
ceptus are at present far from understood, a-fetoprotein
(AFP) is a biological component of the body produced
in high amounts during pregnancy mainly by the fetal
liver, and in certain clinical pathological states. The
biological function of AFP is still unknown, but some
investigators postulate an immunosuppressive role for
the protein during pregnancy. In this study, serum im-
munoglobulin G, M and A levels of 101 gravidas at
different stages of gestation (26 from 11 — 14 weeks, 37
from 32-34 weeks and finally 38 from 38-40 weeks)
were determined and compared to 57 age matched non-
pregnant females. Before being included in the study,
patients were checked for various conditions which po-
tentially alter immunoglobulin and AFP serum levels.
Maternal serum samples showed a significant decreased
concentration of immunoglobulin G (IgG) as compared
to non-pregnancy serum samples (table I). AFP levels
were also quantitated in the pregnancy sera and corre-
lated with immunoglobulins levels. A strongly negative
correlation between AFP and IgG was found through-
out gestation (table II). When gestational age was fixed
and the partial coefficients of correlation calculated, the
inverse correlation persisted. In addition, the relation-
ship between AFP and IgG at the various periods of
gestation (11-14 weeks, 32-34 weeks and 38-40
weeks), calculated in order to detect where the associ-
ation was stronger, revealed significant and uniform
negative correlations (table III). These results do not
prove a true association. In view of other reports indicat-
ing that AFP can block cellular interactions which lead
to IgG production in vitro and in vivo, they may suggest
a possible immunoregulatory function for AFP at the
humoral level during pregnancy.
Keywords: Alpha-fetoprotein, immunoglobulins, pregnancy serum.
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Zusammenfassung
Beziehung zwischen IgG- und AFP-Spiegel während der
Schwangerschaft
Die immunregulatorischen Vorgänge, die sich während
der Schwangerschaft entwickeln und ein Überleben des
semiallogenen Embryos ermöglichen, sind zur Zeit noch
nicht genügend aufgeklärt. Alpha-Fetoprotein (AFP) ist
ein biologischer Bestandteil des Blutes, der während der
Schwangerschaft hauptsächlich in der fetalen Leber und
bei bestimmten Krankheitsbildern in großen Mengen
produziert wird. Die biologische Funktion ist noch un-
bekannt, doch einige Untersuchungen weisen auf die
Bedeutung des Proteins bei der Immunsuppression wäh-
rend der Schwangerschaft hin. In dieser Studie wurden
die Serumspiegel der Immunglobuline G, M und A bei
101 schwangeren Frauen mit unterschiedlichem Gesta-
tionsalter (26 Frauen in der 11.-14. SSW, 37 in der
32.-34. SSW und 38 in der 38.-40. SSW) bestimmt
und mit 57 gleichaltrigen, nichtschwangeren Frauen ver-
glichen. Vor der Messung wurden die Frauen untersucht;
diejenigen, bei den Faktoren vorlagen, die potentiell die
Immunglobulin- und AFP-Spiegel verändern, wurden
von der Studie ausgeschlossen. Bei Schwangeren war die
IgG-Konzentration im Serum bedeutend geringer als bei
Nichtschwangeren (Tab. I). Ebenso wurden die AFP-
Spiegel bei den Schwangeren bestimmt und mit den
Immunglobulinspiegeln verglichen. Während der gesam-
ten Schwangerschaft ergab sich eine stark negative Kor-
relation zwischen AFP und IgG (Tab. II). Bei gleichem
Schwangerschaftsalter und Berechnung der partiellen
Korrelationskoeffizienten blieb es bei einer umgekehrten
Korrelation. Darüber hinaus wollten wir feststellen, ob
es zwischen den einzelnen Schwangerschaftsabschnitten
unterschiedlich starke Korrelationen gab. Es zeigten sich
jedoch in allen Phasen (11.-14. SSW, 32.-34. SSW
und 38.—40. SSW) signifikante, uniforme negative Kor-
relationen (Tab. III). Diese Ergebnisse sind nicht bewei-
send für einen echten Zusammenhang. Es gibt jedoch
andere Studien, die zeigen konnten, daß AFP zelluläre
Interaktionen, die zur IgG-Produktion führen, in vitro
und in vivo blockieren kann. Auf diesem Hintergrund
wäre eine immunregulatorische Funktion des AFP wäh-
rend der Schwangerschaft durchaus vorstellbar.
Schlüsselwörter: Alpha-Fetoprotein, Immunglobuline, Schwangerschaftsserum.
Resume
Relations entre les taux d'immunoglobuline G et d'alpha-
foetoproteine dans le serum de femmes enceintes
Les processus immunoregulateurs qui agissent pendant
la grossesse en permettant la survie du foetus semialloge-
nique ne sont pas connus ä Fheure actuelle. L'alpha-
foetoproteine (AFP) est un composant biologique du
corps produit en grande quantite pendant la grossesse,
surtout par le foie du foetus, mais aussi dans certaines
pathologies cliniques. La fonction biologique de l'AFP
n'est pas encore connue, cependant les chercheurs postu-
lent une fonction immunosupressive pour cette proteine
pendant la grossesse. Nons avons etudie les taux des
immunoglobulines G, M et A dans le serum de 101
femmes enceintes ä differentes periodes de la grossesse
(26 de 11 ä 14 semaines, 37 de 32 a 34 semaines et 38
de 38 ä 40 semaines). Ces taux ont etc compares ä ceux
de 57 femmes non enceintes de meme äge. Avant d'etre
etudiees, les patientes etaient testees pour les differentes
conditions qui pourraient modifier les niveaux d'immu-
noglobulines et d'AFP dans le serum. Les echantillons
de serum maternel etudies ont presente une diminution
significative de la concentration d'immunoglobuline G
(IgG) compare a celle du serum de femmes non enceintes
(tableau I). II a etc trouve une correlation negative tres
grande entre l'AFP et Fig G pendant la grossesse (ta-
bleau II). Quand la periode de grossesse etait fixee et
les coefficientes partiels de correlation etaient calcules,
il persistait la correlation inverse. De plus, la relation
entre l'AFP et FIgG ä differentes periodes de grossesse
(11 a 14 semaines, 32 a 34 semaines et 38 a 40 semaines)
a ete calculee pour detecter Fassociation la plus intense.
Cette relation a montre des correlations negatives signifi-
catives et uniformes (tableau III). Ces resultats ne prou-
vent pas une vraie association. Cependant ils peuvent
suggerer une fonction immunoregulatrice probable de
FAFP au niveau humoral pendant la gestation. Ces
resultats sont en accord avec d'autres montrant le bio-
cage des interactions cellulaires par FAFP induisant la
production d'IgG in vitro et in vivo.
Mots-cles: Alpha-foetoproteine, immunoglobulines, serum des femmes enceintes.
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